Cowpox virus infection: An emerging health threat

Current Opinion in Infectious Diseases

Volumn 21, Issue 2, 2008, Pages 153-156

  Vorou, Rengina M ^a   Papavassiliou, Vassilios G ^a   Pierroutsakos, Ioannis N ^a  

^a Hellenic Center for Disease Control and Prevention   (Greece)

Author keywords

Cowpox; Emerging zoonoses; Rodents

Indexed keywords

CHLORHEXIDINE; CIDOFOVIR; DICLOXACILLIN; FUSIDIC ACID; SMALLPOX VACCINE; ST 247;

COWPOX; COWPOX VIRUS; ELECTRON MICROSCOPY; EXOTIC SPECIES; HOST SUSCEPTIBILITY; HUMAN; INFECTION CONTROL; PROGNOSIS; REVIEW; SEROLOGY; VIRUS ISOLATION; WILD ANIMAL; ZOONOSIS;

ANIMALS; ANTIVIRAL AGENTS; CATS; COMMUNICABLE DISEASES, EMERGING; COWPOX; COWPOX VIRUS; CYTOSINE; HUMANS; PHOSPHONIC ACIDS; ZOONOSES;

EID: 43149111263     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/QCO.0b013e3282f44c74     Document Type: Review

References (27)

1. Pelkonen PM, Tarvainen K, Hynninen A, et al. Cowpox with severe generalized eruption, Finland. Emerg Infect Dis 2003; 9:1458-1471.
2. Czerny CP, Eis-Hubinger AM, Mayr A, et al. Animal poxviruses transmitted from cat to man: current event with lethal end. Zentralbl Veterinarmed B 1991; 38:421-431.
3. Neff JM. Vaccinia virus (cowpox). In:Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. Philadelphia: Churchill Livingstone; 2001. pp. 1553-1554.
4. WHO. WHO technical report. Series 493. WHO expert committee on smallpox eradication, second report. Geneva: World Health Organization; 1972.
5. Chantrey J, Meyer H, Baxby D, et al. Cowpox: reservoir hosts and geographic range. Epidemiol Infect 1999; 122:455-470.
6. Coras B, Essbauer S, Pfeffer M, et al. Cowpox and a cat. Lancet 2005; 375:447.
7. Wolfs TF, Wagenaar JA, Niesters HG, Osterhaus AD. Rat-to-human transmission of Cowpox infection. Emerg Infect Dis 2002; 8:1495-1497.
8. Meyer H, Ropp SL, Esposito JJ. Gene for A-type inclusion body protein is useful for a polymerase chain reaction assay to differentiate orthopoxviruses. J Virol Methods 1997; 74:217-221.
9. Loparev VN, Massung RF, Esposito JJ, Meyer H. Detection and differentiation of old world orthopoxviruses: restriction fragment length polymorphism of the crmB gene region. J Clin Microbiol 2001; 39:94-100.
10. DeClercq E, Neyts J. Therapeutic potential of nucleoside/nucleotide analogues against poxvirus infections. Rev Med Virol 2004; 14:289-300.
11. Yang G, Pevear DC, Davies MH, et al. An orally bioavailable antipoxvirus compound (ST-247) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge. J Virol 2005; 79:13139-13149.
12. Nitsche A, Pauli G. Sporadic human cases of cowpox in Germany. Euro Surveill 2007; 12:E070419.3. This article indicates that human cowpox cases, although sporadic in Germany, exhibit an increased incidence particularly among younger age groups that have not received the smallpox vaccination as this has been an abandoned practice after the eradication of the disease.
13. Wienecke R, Wolff H, Schaller M, et al. Cowpox virus infection in an 11-year-old girl. J Am Acad Dermatol 2000; 42:892-894.
14. Martina BEE, Van Doornum G, Dorrestein GM, et al. Cowpox virus transmission from rats to monkeys, the Netherlands. Emerg Infect Dis 2006; 12:1005-1007.
15. Baxby D, Bennett M. Cowpox: a re-evaluation of the risks of human cowpox based on new epidemiological information. Arch Virol 1997; 13:1-12.
16. Reed KD, Melski JW, Graham MB, et al. The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med 2004; 350:342-350.
17. Schupp P, Pfeffer M, Meyer H, et al. Cowpox virus in a 12-year-old boy: rapid identification by an orthopoxvirus-specific polymerase chain reaction. Br J Dermatol 2001; 145:147-150.
18. Gibbs EP, Johnson RH, Collings DF. Cowpox in a dairy herd in the United Kingdom. Vet Rec 1973; 92:57-74.
19. Yeruham I, Nyska A, Abraham A, Algazi R. Occurrence of cowpox-like lesions in cattle in Israel. Rev Elev Med Vet Pays Trop 1997; 49:299-302.
20. Moss B. Poxviridae: the viruses and their replication. In: Knipe DM, Howley PM, editors. Fields virology, 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. pp. 2849-2883.
21. Damon IK, Esposito JJ. Poxviruses that infect humans. In: Murray PR, Baron EJ, Jorgensen JH, et al., editors. Manual of clinical microbiology. Washington: American Society for Microbiology; 2003. pp. 1583-1591.
22. Laakkonen J, Kallio-Kokko H, Oktem MA, et al. Serological survey for viral pathogens in Turkish rodents. J Wildl Dis 2007; 42:772-777. This is the first serologic study for CPXV in wild rodents in Turkey, highlighting the circulation of CPXV in enzootic foci and its potential to be transmitted to humans.
23. Sandvik T, Tryland M, Hansen H, et al. Naturally occurring orthopoxviruses: potential for recombination with vaccine vectors. J Clin Microbiol 1998; 37:2542-2547.
24. Baxby D, Bennett M, Getty B. Human cowpox 1979-93: a review based on 54 cases. Br J Dermatol 1994; 131:598-707.
25. Tryland M, Sandvik T, Mehl R, et al. Serological evidence for orthopoxvirus infection in Norwegian rodents and shrews. J Wildl Dis 1998; 34:240-250.
26. Baxby D, Ashton DG, Jones DM, Thomsett LR. An outbreak of cowpox in captive cheetahs: virological and epidemiological studies. J Hyg 1982; 89:365-372.
27. Fenner F. The Florey lecture, 1983. Biological control, as exemplified by smallpox eradication and myxomatosis. Proc R Soc Lond B Biol Sci 1983; 218:259-285.